Top

Journal of Gastrointestinal Surgery

Published in:

01-03-2014 | Original Article

Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study

Authors: Xianwu Luo, Lei Yuan, Yi Wang, Ruiliang Ge, Yanfu Sun, Gongtian Wei

Published in: Journal of Gastrointestinal Surgery | Issue 3/2014

Abstract

Background

Surgical resection is currently indicated for all potentially resectable intrahepatic cholangiocarcinoma (ICC), but the survival outcomes and the prognostic factors have not been well-documented due to its rarity. This study aims to assess these in a large, consecutive series of patients with ICC treated surgically.

Methods

A retrospective study was conducted on 1,333 ICC patients undergoing surgery between January 2007 and December 2011. Surgical results and survival were evaluated and compared among different subgroups of patients. Univariate and multivariate analyses were performed to identify prognostic factors.

Results

R0, R1, R2 resection and exploratory laparotomy were obtained in 34.8, 44.9, 16.4, and 3.9 % of the patients, respectively. The overall 1-, 3-, and 5-year survival rates for the entire cohort were 58.2, 25.2, and 17.0 %, respectively, with corresponding rates of 79.1, 42.6, and 28.7 % for patients with R0 resection; 60.5, 20.1, and 13.9 % for patients with R1 resection; 20.5, 7.4, and 0 % for patients with R2 resection; and 3.8, 0, and 0 % for patients with an exploratory laparotomy. Independent factors for poor survival included positive resection margin, lymph node metastasis, multiple tumors, vascular invasion, and elevated CA19-9 and/or CEA, whereas hepatitis B virus infection and cirrhosis were independently favorable prognosis indicators.

Conclusions

R0 resection offers the best possibility of long-term survival, but the chance of a R0 resection is low when surgery is performed for potential resectable ICC. Further randomized trials are warranted to refine indications for surgery in the management of ICC.

Patel T. Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol 2011;8:189–200.PubMedCentralPubMedCrossRef

Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303–14.PubMedCrossRef

Poultsides GA, Zhu AX, Choti MA, Pawlik TM. Intrahepatic cholangiocarcinoma. Surg Clin North Am 2010;90:817–37.PubMedCrossRef

Sempoux C, Jibara G, Ward S, Fan C, Qin L, Roayaie S et al. Intrahepatic Cholangiocarcinoma: New Insights in Pathology. Seminars in Liver Disease 2011;31:049–60.CrossRef

Lang H, Sotiropoulos GC, Fruhauf NR, Domland M, Paul A, Kind EM et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 2005;241:134–43.PubMed

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008;248:84–96.PubMedCrossRef

Tan JC, Coburn NG, Baxter NN, Kiss A, Law CH. Surgical management of intrahepatic cholangiocarcinoma--a population-based study. Ann Surg Oncol 2008;15:600–8.PubMedCrossRef

Jonas S, Thelen A, Benckert C, Biskup W, Neumann U, Rudolph B et al. Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 2009;249:303–9.PubMedCrossRef

Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998;187:365–72.PubMedCrossRef

10.

Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69:1633–7.PubMedCrossRef

11.

Weimann A, Varnholt H, Schlitt HJ, Lang H, Flemming P, Hustedt C et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 2000;87:1182–7.PubMedCrossRef

12.

DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007;245:755–62.PubMedCrossRef

13.

Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg 2011;254:824–9.PubMedCrossRef

14.

Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S et al. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2005;12:479–83.PubMedCrossRef

15.

Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol 2007;96:160–5.PubMedCrossRef

16.

Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM et al. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 2008;143:366–74.PubMedCrossRef

17.

Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008;15:2787–94.PubMedCrossRef

18.

Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S et al. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol 2010;17:1816–22.PubMedCrossRef

19.

de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140–5.PubMedCrossRef

20.

Uchiyama K, Yamamoto M, Yamaue H, Ariizumi S, Aoki T, Kokudo N et al. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2011;18:443–52.PubMedCrossRef

21.

Li YY, Li H, Lv P, Liu G, Li XR, Tian BN et al. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment. J Gastrointest Surg 2011;15:608–13.PubMedCrossRef

22.

Nanashima A, Sumida Y, Abo T, Nagasaki T, Takeshita H, Fukuoka H et al. Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology. 2007;54(80):2337–42.PubMed

23.

Jan YY, Yeh CN, Yeh TS, Chen TC. Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol. 2005;11(12):1779–84.PubMed

24.

Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg 2007;11:1488–96.PubMedCrossRef

25.

Dhanasekaran R, Hemming AW, Zendejas I, Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep. 2013;29(4):1259–67.PubMed

26.

Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013;31:1188–95.PubMedCrossRef

27.

Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004;40:472–7.PubMedCrossRef

28.

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–4.PubMedCrossRef

29.

Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2010;26:269–73.PubMedCrossRef

30.

The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg 1989; 19:98–129.

31.

Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ, Qin LX et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2009;135:1073–80.PubMedCrossRef

32.

Tamandl D, Kaczirek K, Gruenberger B, Koelblinger C, Maresch J, Jakesz R et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 2009;96:919–25.PubMedCrossRef

33.

Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525–31.PubMedCrossRef

34.

Sotiropoulos GC, Bockhorn M, Sgourakis G, Brokalaki EI, Molmenti EP, Neuhäuser M et al. R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci. 2009;54(4):887–94.PubMedCrossRef

35.

Zhou HB, Wang H, Li YQ, Li SX, Zhou DX, Tu QQ et al. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011;17:1292–1303.PubMedCrossRef

36.

Puhalla H, Schuell B, Pokorny H, Kornek GV, Scheithauer W, Gruenberger T. Treatment and outcome of intrahepatic cholangiocellular carcinoma. Am J Surg 2005;189:173–7.PubMedCrossRef

37.

Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005;29:728–33.PubMedCrossRef

38.

Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 2008;23:766–70.PubMedCrossRef

39.

Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 2006;41:893–900.PubMedCrossRef

40.

Lang H, Sotiropoulos GC, Sgourakis G, Schmitz KJ, Paul A, Hilgard P et al. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 2009;208:218–28.PubMedCrossRef

41.

Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009;16:14–22.PubMedCrossRef

42.

Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003;10:432–40.PubMedCrossRef

43.

Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001;92:2374–83.PubMedCrossRef

44.

Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–7.PubMedCrossRef

45.

Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg. 2006;244(2):260–4.PubMedCrossRef

46.

Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 2001;88:1463–6.PubMedCrossRef

47.

Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Shuto T et al. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma. Hepatogastroenterology 2003;50:1069–72.PubMed

48.

Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000;127:498–505.PubMedCrossRef

49.

Rana A, Hong JC. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2012;28:258–65.PubMedCrossRef

50.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL et al. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients. Cancer J 2006;12:113-22.PubMed

Title: Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study
Authors: Xianwu Luo
Lei Yuan
Yi Wang
Ruiliang Ge
Yanfu Sun
Gongtian Wei
Publication date: 01-03-2014
Publisher: Springer US
Published in: Journal of Gastrointestinal Surgery / Issue 3/2014
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-013-2447-3

At a glance: The STEP trials

Springer Medicine

Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2014

Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors

Gastrectomy in Advanced Gastric Cancer Effectively Palliates Symptoms and May Improve Survival in Select Patients

Image Findings in Celiac Artery Stenosis Due to Median Arcuate Ligament Compression

Does Preoperative Cross-Sectional Imaging Accurately Predict Main Duct Involvement in Intraductal Papillary Mucinous Neoplasm?

Effect of Body Mass Index in Patients Undergoing Resection for Gastric Cancer: A Single Center US Experience

Resection of Isolated Renal Cell Carcinoma Metastases of the Pancreas: Outcomes from the Johns Hopkins Hospital